| Mrs Katelyn Piddington, PHARMD | |
|
1705 Us Highway 51 And 138, Stoughton, WI 53589-1907 | |
| (608) 873-7612 | |
| Not Available |
| Full Name | Mrs Katelyn Piddington |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1705 Us Highway 51 And 138, Stoughton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407589963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 21310-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Katelyn Piddington, PHARMD 1705 Us Highway 51 And 138, Stoughton, WI 53589-1907 Ph: (608) 873-7612 | Mrs Katelyn Piddington, PHARMD 1705 Us Highway 51 And 138, Stoughton, WI 53589-1907 Ph: (608) 873-7612 |
News Archive
Duke University researchers have now shown that selectively killing the population of regulatory T cells in cancer patients - cells that normally function to restrain the activity of the immune response - improves the ability of a cancer vaccine to stimulate tumor-specific T cells.
Delivering drugs to the lungs via inhalation has a number of potential advantages over traditional routes of administration like pills or injections. For treating pulmonary diseases, the obvious logic we are applying is topical delivery to the airways via inhalation.
Dr. Paul Fidel, the Carl Baldridge Professor and Associate Dean for Research at LSU Health Sciences Center New Orleans' School of Dentistry, is the lead principal investigator of a $2.76 million grant from the National Institute of Dental and Craniofacial Research over five years to study how HIV and antiretroviral therapy may change communities of bacteria in the mouth and what effects those changes may have on oral infections in HIV disease.
The Global Antibiotic Research and Development Partnership, the Clinton Health Access Initiative and Shionogi & Co., Ltd today announced a Memorandum of Understanding to accelerate access, including in low- and middle-income countries, to the antibiotic cefiderocol for bacterial infections in patients with limited treatment options.
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier.
› Verified 2 days ago
Alfred Bennin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 Us Hwy 51/138, Stoughton, WI 53589 Phone: 608-873-7612 | |
Holly Tangeman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 Us Highway 51 And 138, Stoughton, WI 53589 Phone: 608-773-7612 | |
Ms. Marilyn Mary Mackinnon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 Highway Fifty One, Stoughton, WI 53589 Phone: 608-873-7612 Fax: 608-873-7894 | |
Dr. Mary Lynn Driscoll, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Hwy 138, Stoughton, WI 53589 Phone: 608-873-9262 Fax: 608-873-5496 | |
Dr. Adam Keith Lindsay, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 State Hwy 138, Stoughton, WI 53589 Phone: 608-873-9262 | |
Tina Ann Ferguson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 Us Highway 51, Stoughton, WI 53589 Phone: 608-873-7612 |